Company profilePharmaceutical#363 of 1,318 in Pakistan✓ No DRAP alerts

Misaq Pharmaceuticals Pvt Ltd.

Pharmaceutical company · 47 brands · 44 molecules

47 registered products 29 pharmaceutical brands 44 distinct molecules 0 DRAP alerts

Company overview

47
registered products
29
pharmaceutical brands
44
distinct molecules
0
therapeutic classes
0
DRAP alerts

Misaq Pharmaceuticals Pvt Ltd. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 47 product registrations across 44 distinct molecules. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Misaq

34 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

34
ceilings with an approval date
0
not revised in 2+ years
2025
oldest approval year
202534

Top molecules by brand count

Cefixime3 brands
Azithromycin3 brands
Omeprazole2 brands
Meropenem2 brands
Povidone-Iodine2 brands
Linezolid ...... 100/2 brands
Levofloxacin2 brands
Phytonadione2 brands

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official60 products · Rs 156.71 – Rs 4,913.56
Median across source: Rs 457.58

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

MEDISAVE PHARMACEUTICALS holds 56 molecules not in this portfolio
Aluminum HydroxideAmikacinAmlodipineArtemetherAscorbic AcidCefoperazone
BIO LABS (PVT) LTD. holds 128 molecules not in this portfolio
000 I.UAmlodipineAprepitantAremetherArtemetherArtesunate
HIGH - Q INTERNATIONAL holds 129 molecules not in this portfolio
000 I.UAcetyl L-CarnitineAmikacinAmlodipineAnastrozoleAprepitant

Get the full profile for Misaq

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.